Unprecedented data sharing driving new rare disease diagnoses in Europe

by Centre for Genomic Regulation

​Rare disease experts detail the first results of an unprecedented collaboration to diagnose people living with unsolved cases of rare diseases across Europe. The findings are published today in a s...

Read more

Towards a treatment for myotonic dystrophy: the first 3D model with patient cells

by IBEC - Institut de Bioenginyeria de Catalunya

IBEC researchers led by Javier Ramón and Juan M. Fernández develop the first three-dimensional model for myotonic dystrophy, a rare disease that currently has no cure. The model combines patient cel...

Read more

Research on rare diseases at the Institute for Advanced Chemistry of Catalonia

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

​ Within all the research lines carried out at the Institute for Advanced Chemistry of Catalonia of the Spanish National Research Council (CSIC), seven research groups dedicate part of their effo...

Read more

Catalytic Impact Foundation Invests in Oncoheroes Biosciences Endorsing Its Unique Effort To Treat Childhood Cancers

by Oncoheroes Biosciences

Childhood cancer is considered a rare disease that accounts for about 1% of all U.S. cancer diagnoses. Although pediatric cancer death rates have declined over the past four decades due to improved tu...

Read more

New drug confirmed as a potential therapeutic agent for a rare disease, Friedreich's Ataxia

by IRB Lleida. Institut de Recerca Biomèdica

A recent study has confirmed the benefits of the drug leriglitazone in treating Friedrich's Ataxia, a rare disease that affects 2-4 people in 100,000 and for which there is currently no effective cure...

Read more

VHIR obtains more than €1 million from the use of a patent

by CataloniaBio

The Vall d’Hebron​ Research Institute (VHIR) obtained more than €1 million in profit from the use of a patent of a new treatment for a mitochondrial rare disease caused by TK2 deficiency. It is ...

Read more

Identifican el mecanismo que desencadena un tipo raro de distrofia muscular

by Universitat Autònoma de Barcelona (UAB)

A study led by the IBB-UAB has identified the molecular mechanism through which a protein, when carrying genetic mutations associated with a rare disease known as limb-girdle muscular dystrophy, type ...

Read more

Precipita platform raises funds for research in Cornelia de Lange syndrome at IDIBELL

by IBEC - Institut de Bioenginyeria de Catalunya

The campaign started at Precipita crowdfunding platform aims to raise 25,000 euros for sequencing the genome of several patients looking for several markers that may be useful both for understanding t...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

La impronta inmunológica condiciona la ...

by Hospital Universitari de Bellvitge

Un estudio del Hospital de Bellvitge, el IDIBELL y la Icahn School of ...

Photos Stream